Top Pain Management Therapeutics Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Pain Management Therapeutics Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Pain Management Therapeutics industry players.

Pain Management Therapeutics Market Competitive Landscape

Global pain management therapeutics market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Top Players in Pain Management Therapeutics Market

  • CSL Behring (Australia) 
  • Takeda Pharmaceutical Company Limited (Japan) 
  • Pharming Group N.V. (Netherlands) 
  • BioCryst Pharmaceuticals, Inc. (USA) 
  • Ionis Pharmaceuticals, Inc. (USA) 
  • Sanofi S.A. (France) 
  • Adverum Biotechnologies, Inc. (USA) 
  • KalVista Pharmaceuticals, Inc. (USA) 
  • Attune Pharmaceuticals, Inc. (USA) 
  • Arrowhead Pharmaceuticals, Inc. (USA) 
  • Amgen Inc. (USA) 
  • BioMarin Pharmaceutical Inc. (USA) 
  • Catalyst Biosciences, Inc. (USA) 
  • RUCONEST (Pharming Group N.V., Netherlands) 
  • Haegarda (CSL Limited, Australia) 
  • Firazyr (Shire plc, UK) 
  • Shire plc (UK) 
  • Dyax Corp. (USA) 
  • Adverum Biotechnologies, Inc. (USA) 
  • Amgen Inc. (USA)

Pain Management Therapeutics Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Pain Management Therapeutics Market size was valued at USD 78.7 billion in 2023 and is poised to grow from USD 81.53 billion in 2024 to USD 108.2 billion by 2032, growing at a CAGR of 3.6% during the forecast period (2025-2032). 

Global pain management therapeutics market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'CSL Behring (Australia) ', 'Takeda Pharmaceutical Company Limited (Japan) ', 'Pharming Group N.V. (Netherlands) ', 'BioCryst Pharmaceuticals, Inc. (USA) ', 'Ionis Pharmaceuticals, Inc. (USA) ', 'Sanofi S.A. (France) ', 'Adverum Biotechnologies, Inc. (USA) ', 'KalVista Pharmaceuticals, Inc. (USA) ', 'Attune Pharmaceuticals, Inc. (USA) ', 'Arrowhead Pharmaceuticals, Inc. (USA) ', 'Amgen Inc. (USA) ', 'BioMarin Pharmaceutical Inc. (USA) ', 'Catalyst Biosciences, Inc. (USA) ', 'RUCONEST (Pharming Group N.V., Netherlands) ', 'Haegarda (CSL Limited, Australia) ', 'Firazyr (Shire plc, UK) ', 'Shire plc (UK) ', 'Dyax Corp. (USA) ', 'Adverum Biotechnologies, Inc. (USA) ', 'Amgen Inc. (USA)'

The growing cases of various diseases, in addition to the associated pain and aches, are contributing to the expansion of the pain management therapeutics market. Pain can be caused by a variety of conditions, including ulcers, osteoarthritis, chronic arthritis, multiple sclerosis, cancer, and diabetic neuropathy. Pain management therapeutics are effective in treating everything from short-term acute pain to long-term chronic pain. Global market growth is being stimulated by growing preference for pain management.

The emphasis is increasingly shifting toward personalised drugs, biologics, and quick-acting lifestyle medicines, which account for more than 70% of all medications in development.

North America held the largest global pain management therapeutics market share in terms of revenue in 2021, followed by Europe and Asia Pacific, and is predicted to continue the lead during the forecast period. North American companies are heavily involved in research and development efforts for developing new pain management drugs, resulting in driving the global pain management therapeutics market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Pain Management Market
Buy Now GET FREE SAMPLE
Pain Management Devices Market
Buy Now GET FREE SAMPLE
Topical Pain Relief Market
Buy Now GET FREE SAMPLE
Veterinary Pain Management Market
Buy Now GET FREE SAMPLE
Joint Pain Injections Market
Buy Now GET FREE SAMPLE
Analgesics Market
Buy Now GET FREE SAMPLE
Neuropathic Pain Market
Buy Now GET FREE SAMPLE
Fibromyalgia Treatment Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Pain Management Therapeutics Market
Pain Management Therapeutics Market

Report ID: SQMIG35F2004

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE